Safety and Tolerability of JSKN003 in Chinese Subjects With Advanced Solid Tumors

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Safety and Tolerability of JSKN003 in Chinese Subjects With Advanced Solid Tumors	Advanced Solid Tumor	Active, not recruiting	Phase 1 / Phase 2	2026-02-02		NCT05744427

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Jiangsu Alphamab Biopharmaceuticals Co., Ltd	17

34 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Affiliated Cancer Hospital of Fudan University	Shanghai	China	2
Affiliated Cancer Hospital of Guangxi Medical University	Nanning	China	1
Affiliated Cancer Hospital of Harbin Medical University	Ha’erbin	China	1
Affiliated Hospital of Qingdao University	Qingdao	China	5
Anhui Provincal Hospital	Hefei	China	1
Beijing Cancer Hospital	Beijing	China	85
Beijing Friendship Hospital	Beijing	China	9
Beijing Luhe Hospital	Beijing	China	3
Changhai Hospital	Shanghai	China	21
Fudan University Shanghai Cancer Center	Shanghai	China	128
Fujian Cancer Hospital	Fuzhou	China	37
Gulou Hospital Affiliated to Nanjing University School of Medicine	Nanjing	China	1
Hunan Cancer Hospital	Changsha	China	47
Jiangsu Cancer Hospital	Nanjing	China	14
Jiangsu Provincial People's Hospital	Nanjing	China	8
Linyi City Cancer Hospital	Linyi	China	1
Linyi City People's Hospital	Linyi	China	1
Nantong Cancer Hospital	Nantong	China	1
Run Run Shaw Hospital, Zhejiang University School of Medicine	Hangzhou	China	1
Shandong Cancer Hospital	Jinan	China	19
Shanghai East Hospital	Shanghai	China	33
Sun Yat-sen Memorial Hospital, Sun Yat-sen University	Guangzhou	China	24
Sun Yat-sen University Cancer Prevention Center	Guangzhou	China	1
The First Affiliated Hospital of Henan University of Science and Technology	Luoyang	China	13
The First Affiliated Hospital of Nanjing Medical University/Jiangsu Provincial People's Hospital	Nanjing	China	1

Clinical trials